Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Optimising prophylaxis outcomes and costs in haemophilia patients switching to recombinant FVIII-Fc: a single-centre real-world experience.

Tagliaferri A, Matichecchia A, Rivolta GF, Riccardi F, Quintavalle G, Benegiamo A, Rossi R, Coppola A.

Blood Transfus. 2019 Nov 4:1-11. doi: 10.2450/2019.0220-19. [Epub ahead of print]

2.

Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study.

Gobbini E, Chiari R, Pizzutillo P, Bordi P, Ghilardi L, Pilotto S, Osman G, Cappuzzo F, Cecere F, Riccardi F, Scotti V, Martelli O, Borra G, Maiello E, Rossi A, Graziano P, Gregorc V, Casartelli C, Sergi C, Del Conte A, Delmonte A, Bareggi C, Cortinovis D, Rizzo P, Tabbò F, Rossi G, Bria E, Galetta D, Tiseo M, Di Maio M, Novello S.

Clin Transl Oncol. 2019 Oct 19. doi: 10.1007/s12094-019-02222-8. [Epub ahead of print]

PMID:
31630357
3.

Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations.

Panzuto F, Puscedddu S, Faggiano A, Rinzivillo M, Brighi N, Prinzi N, Riccardi F, Iannicelli E, Maggio I, Femia D, Tafuto S, Manuzzi L, Di Sarno A, Annibale B, de Braud F, Campana D; Itanet (Italian Association for Neuroendocrine Tumours).

Pancreatology. 2019 Dec;19(8):1067-1073. doi: 10.1016/j.pan.2019.09.015. Epub 2019 Sep 30.

PMID:
31587962
4.

Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor.

Lamberti G, Faggiano A, Brighi N, Tafuto S, Ibrahim T, Brizzi MP, Pusceddu S, Albertelli M, Massironi S, Panzuto F, Badalamenti G, Riccardi F, Butturini G, Gelsomino F, De Divitiis C, Modica R, Bongiovanni A, La Salvia A, Torchio M, Colao A, Ferone D, Campana D.

J Clin Endocrinol Metab. 2020 Jan 1;105(1). pii: dgz035. doi: 10.1210/clinem/dgz035.

PMID:
31545377
5.

Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion.

La Monica S, Minari R, Cretella D, Bonelli M, Fumarola C, Cavazzoni A, Galetti M, Digiacomo G, Riccardi F, Petronini PG, Tiseo M, Alfieri R.

Target Oncol. 2019 Oct;14(5):619-626. doi: 10.1007/s11523-019-00669-x.

PMID:
31502118
6.

Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study.

Cazzaniga ME, Pinotti G, Montagna E, Amoroso D, Berardi R, Butera A, Cagossi K, Cavanna L, Ciccarese M, Cinieri S, Cretella E, De Conciliis E, Febbraro A, Ferraù F, Ferzi A, Fiorentini G, Fontana A, Gambaro AR, Garrone O, Gebbia V, Generali D, Gianni L, Giovanardi F, Grassadonia A, Leonardi V, Marchetti P, Melegari E, Musolino A, Nicolini M, Putzu C, Riccardi F, Santini D, Saracchini S, Sarobba MG, Schintu MG, Scognamiglio G, Spadaro P, Taverniti C, Toniolo D, Tralongo P, Turletti A, Valenza R, Valerio MR, Vici P, Clivio L, Torri V; VICTOR Study Group.

Breast. 2019 Dec;48:7-16. doi: 10.1016/j.breast.2019.07.006. Epub 2019 Aug 22.

PMID:
31470257
7.

Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract: A case report.

Pirozzi A, Riccardi F, Arpino G, Mocerino C, Campione S, Molino C, Cartenì G.

Medicine (Baltimore). 2019 Jul;98(29):e16508. doi: 10.1097/MD.0000000000016508.

8.

Multiple venous malformations revealing a familial cerebral cavernomatosis.

Benzaquen M, Fareau J, Riccardi F, Philip-Sarles N, Bertrand F, Berbis P, Delaporte E.

Clin Exp Dermatol. 2019 Jul 19. doi: 10.1111/ced.14051. [Epub ahead of print] No abstract available.

PMID:
31323127
9.

Evaluation of a Companion Robot for Individuals With Dementia: Quantitative Findings of the MARIO Project in an Irish Residential Care Setting.

Barrett E, Burke M, Whelan S, Santorelli A, Oliveira BL, Cavallo F, Dröes RM, Hopper L, Fawcett-Henesy A, Meiland FJM, Mountain G, Moyle W, Raciti M, Pegman G, Teare A, Sancarlo D, Riccardi F, D'Onofrio G, Giuliani F, Russo A, Bleaden A, Greco A, Casey D.

J Gerontol Nurs. 2019 Jul 1;45(7):36-45. doi: 10.3928/00989134-20190531-01.

PMID:
31237660
10.

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial.

Perrone F, De Laurentiis M, De Placido S, Orditura M, Cinieri S, Riccardi F, Ribecco AS, Putzu C, Del Mastro L, Rossi E, Tinessa V, Mosconi AM, Nuzzo F, Di Rella F, Gravina A, Iodice G, Landi G, Pacilio C, Forestieri V, Lauria R, Fabbri A, Ibrahim T, De Maio E, Barni S, Gori S, Simeon V, Arenare L, Daniele G, Piccirillo MC, Normanno N, de Matteis A, Gallo C.

Eur J Cancer. 2019 Sep;118:178-186. doi: 10.1016/j.ejca.2019.05.004. Epub 2019 Jun 1.

PMID:
31164265
11.

Rescue of spinal muscular atrophy mouse models with AAV9-Exon-specific U1 snRNA.

Donadon I, Bussani E, Riccardi F, Licastro D, Romano G, Pianigiani G, Pinotti M, Konstantinova P, Evers M, Lin S, Rüegg MA, Pagani F.

Nucleic Acids Res. 2019 Aug 22;47(14):7618-7632. doi: 10.1093/nar/gkz469.

12.

Genetics of neonatal onset epilepsies: An overview.

Milh M, Riccardi F, Denis J.

Rev Neurol (Paris). 2019 May 13. pii: S0035-3787(18)30953-6. doi: 10.1016/j.neurol.2019.01.396. [Epub ahead of print] Review.

PMID:
31097300
13.

Quality parameters of hunted game meat: Sensory analysis and pH monitoring.

Viganò R, Demartini E, Riccardi F, Corradini A, Besozzi M, Lanfranchi P, Chiappini PL, Cottini A, Gaviglio A.

Ital J Food Saf. 2019 Mar 28;8(1):7724. doi: 10.4081/ijfs.2019.7724. eCollection 2019 Mar 18.

14.

Incidental finding of non-Hodgkin's lymphoma in a patient affected by castration-sensitive prostate cancer: A case report.

Pirozzi A, Cartenì G, Scagliarini S, Fusco M, Riccardi F.

Medicine (Baltimore). 2019 Mar;98(11):e14805. doi: 10.1097/MD.0000000000014805.

15.

Therapeutic sequences in patients with grade 1-2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group.

Faggiano A, Di Maio S, Mocerino C, Ottaviano M, De Divitiis C, Guarnotta V, Dolce P, Modica R, Puliafito I, Tozzi L, Di Sarno A, Leo S, Riccardi F, Palmieri G, Tafuto S, Bianco A, Badalamenti G, Colao A; ELIOS.

Endocrine. 2019 Nov;66(2):417-424. doi: 10.1007/s12020-019-01894-0. Epub 2019 Mar 14.

PMID:
30875056
16.

A patient with a novel CNTNAP2 homozygous variant: further delineation of the CASPR2 deficiency syndrome and review of the literature.

Riccardi F, Urquhart J, McCullagh G, Lawrence P, Douzgou S.

Clin Dysmorphol. 2019 Apr;28(2):66-70. doi: 10.1097/MCD.0000000000000259. No abstract available.

PMID:
30762603
17.

Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study.

Hescot S, Curras-Freixes M, Deutschbein T, van Berkel A, Vezzosi D, Amar L, de la Fouchardière C, Valdes N, Riccardi F, Do Cao C, Bertherat J, Goichot B, Beuschlein F, Drui D, Canu L, Niccoli P, Laboureau S, Tabarin A, Leboulleux S, Calsina B, Libé R, Faggiano A, Schlumberger M, Borson-Chazot F, Mannelli M, Gimenez-Roqueplo AP, Caron P, Timmers HJLM, Fassnacht M, Robledo M, Borget I, Baudin E; European Network for the Study of Adrenal Tumors (ENS@T).

J Clin Endocrinol Metab. 2019 Jun 1;104(6):2367-2374. doi: 10.1210/jc.2018-01968.

PMID:
30715419
18.

Enteral versus intravenous approach for the sedation of critically ill patients: a randomized and controlled trial.

Mistraletti G, Umbrello M, Salini S, Cadringher P, Formenti P, Chiumello D, Villa C, Russo R, Francesconi S, Valdambrini F, Bellani G, Palo A, Riccardi F, Ferretti E, Festa M, Gado AM, Taverna M, Pinna C, Barbiero A, Ferrari PA, Iapichino G; SedaEN investigators.

Crit Care. 2019 Jan 7;23(1):3. doi: 10.1186/s13054-018-2280-x.

19.

A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study.

Gagno S, D'Andrea MR, Mansutti M, Zanusso C, Puglisi F, Dreussi E, Montico M, Biason P, Cecchin E, Iacono D, Russo S, Cinausero M, Saracchini S, Gasparini G, Sartori D, Bari M, Collovà E, Meo R, Merkabaoui G, Spagnoletti I, Pellegrino A, Gianni L, Sandri P, Cretella E, Vattemi E, Rocca A, Serra P, Fabbri MA, Benedetti G, Foghini L, Medici M, Basso U, Amoroso V, Riccardi F, Baldelli AM, Clerico M, Bonura S, Saggia C, Innocenti F, Toffoli G.

Clin Breast Cancer. 2019 Apr;19(2):137-145.e4. doi: 10.1016/j.clbc.2018.11.009. Epub 2018 Nov 24.

20.

The entity of thermal-crush-avulsion hand injury (hot-press roller burns) treated with fast acting debriding enzymes (nexobrid): literature review and report of first case.

Di Castri A, Quarta L, Mataro I, Riccardi F, Pezone G, Giordano L, Shoham Y, Rosenberg L, Caleffi E.

Ann Burns Fire Disasters. 2018 Mar 31;31(1):31.

21.

Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safety.

Riccardi F, Colantuoni G, Diana A, Mocerino C, Cartenì G, Lauria R, Febbraro A, Nuzzo F, Addeo R, Marano O, Incoronato P, De Placido S, Ciardiello F, Orditura M.

Mol Clin Oncol. 2018 Sep;9(3):255-263. doi: 10.3892/mco.2018.1672. Epub 2018 Jul 16.

22.

Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials.

Gridelli C, Morabito A, Cavanna L, Luciani A, Maione P, Bonanno L, Filipazzi V, Leo S, Cinieri S, Ciardiello F, Burgio MA, Bilancia D, Cortinovis D, Rosetti F, Bianco R, Gebbia V, Artioli F, Bordonaro R, Fregoni V, Mencoboni M, Nelli F, Riccardi F, di Isernia G, Costanzo R, Rocco G, Daniele G, Signoriello S, Piccirillo MC, Gallo C, Perrone F.

J Clin Oncol. 2018 Sep 1;36(25):2585-2592. doi: 10.1200/JCO.2017.76.8390. Epub 2018 Jul 20.

PMID:
30028656
23.

Inhibitors in Hemophilia B.

Santoro C, Quintavalle G, Castaman G, Baldacci E, Ferretti A, Riccardi F, Tagliaferri A.

Semin Thromb Hemost. 2018 Sep;44(6):578-589. doi: 10.1055/s-0038-1660817. Epub 2018 Jun 20. Review.

PMID:
29925096
24.

Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities.

Le Roy A, Prébet T, Castellano R, Goubard A, Riccardi F, Fauriat C, Granjeaud S, Benyamine A, Castanier C, Orlanducci F, Ben Amara A, Pont F, Fournié JJ, Collette Y, Mege JL, Vey N, Olive D.

Front Immunol. 2018 May 4;9:977. doi: 10.3389/fimmu.2018.00977. eCollection 2018.

25.

Abnormal function of the UBA5 protein in a case of early developmental and epileptic encephalopathy with suppression-burst.

Mignon-Ravix C, Milh M, Kaiser CS, Daniel J, Riccardi F, Cacciagli P, Nagara M, Busa T, Liebau E, Villard L.

Hum Mutat. 2018 Jul;39(7):934-938. doi: 10.1002/humu.23534. Epub 2018 May 3.

PMID:
29663568
26.

Clinical features and therapeutic challenges of cytopenias belonging to alps and alps-related (ARS) phenotype.

Palmisani E, Miano M, Micalizzi C, Calvillo M, Pierri F, Terranova P, Lanza T, Lanciotti M, Riccardi F, Todiere A, Zanardi S, Caviglia I, Dufour C, Fioredda F.

Br J Haematol. 2019 Mar;184(5):861-864. doi: 10.1111/bjh.15178. Epub 2018 Mar 12. No abstract available.

PMID:
29527658
27.

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial.

De Placido S, Gallo C, De Laurentiis M, Bisagni G, Arpino G, Sarobba MG, Riccardi F, Russo A, Del Mastro L, Cogoni AA, Cognetti F, Gori S, Foglietta J, Frassoldati A, Amoroso D, Laudadio L, Moscetti L, Montemurro F, Verusio C, Bernardo A, Lorusso V, Gravina A, Moretti G, Lauria R, Lai A, Mocerino C, Rizzo S, Nuzzo F, Carlini P, Perrone F; GIM Investigators.

Lancet Oncol. 2018 Apr;19(4):474-485. doi: 10.1016/S1470-2045(18)30116-5. Epub 2018 Feb 23. Erratum in: Lancet Oncol. 2018 Apr;19(4):e184.

PMID:
29482983
28.

Further Theoretical Insight into the Mechanical Properties of Polycaprolactone Loaded with Organic-Inorganic Hybrid Fillers.

Maietta S, Russo T, Santis R, Ronca D, Riccardi F, Catauro M, Martorelli M, Gloria A.

Materials (Basel). 2018 Feb 21;11(2). pii: E312. doi: 10.3390/ma11020312.

29.

Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis.

De Angelis C, Di Maio M, Crispo A, Giuliano M, Schettini F, Bonotto M, Gerratana L, Iacono D, Cinausero M, Riccardi F, Ciancia G, De Laurentiis M, Puglisi F, De Placido S, Arpino G.

Oncotarget. 2017 Nov 24;8(68):112816-112824. doi: 10.18632/oncotarget.22643. eCollection 2017 Dec 22.

30.

Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial results.

De Placido S, Giuliano M, Schettini F, Von Arx C, Buono G, Riccardi F, Cianniello D, Caputo R, Puglisi F, Bonotto M, Fabi A, Bilancia D, Ciccarese M, Lorusso V, Michelotti A, Bruzzese D, Veneziani BM, Locci M, De Laurentiis M, Arpino G.

Breast. 2018 Apr;38:86-91. doi: 10.1016/j.breast.2017.12.012. Epub 2018 Jan 4.

PMID:
29287189
31.

Feasibility and Effectiveness of Tuberculosis Active Case-Finding among Children Living with Tuberculosis Relatives: a Cross-Sectional Study in Guinea-Bissau.

Bosa L, Da Silva L, Mendes DV, Sifna A, Sargento Mendes M, Riccardi F, Colombatti R.

Mediterr J Hematol Infect Dis. 2017 Oct 15;9(1):e2017059. doi: 10.4084/MJHID.2017.059. eCollection 2017.

32.

Tuberculosis Case Finding With Combined Rapid Point-of-Care Assays (Xpert MTB/RIF and Determine TB LAM) in HIV-Positive Individuals Starting Antiretroviral Therapy in Mozambique.

Floridia M, Ciccacci F, Andreotti M, Hassane A, Sidumo Z, Magid NA, Sotomane H, David M, Mutemba E, Cebola J, Mugunhe RJ, Riccardi F, Marazzi MC, Giuliano M, Palombi L, Mancinelli S.

Clin Infect Dis. 2017 Nov 13;65(11):1878-1883. doi: 10.1093/cid/cix641.

PMID:
29020319
33.

Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study.

Gobbini E, Galetta D, Tiseo M, Graziano P, Rossi A, Bria E, Di Maio M, Rossi G, Gregorc V, Riccardi F, Scotti V, Ceribelli A, Buffoni L, Delmonte A, Franchina T, Migliorino MR, Cortinovis D, Pisconti S, Bordi P, Catino A, Maiello E, Arizio F, Novello S; other Co-Authors.

Lung Cancer. 2017 Sep;111:30-37. doi: 10.1016/j.lungcan.2017.06.009. Epub 2017 Jun 16.

PMID:
28838394
34.

Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial).

Orditura M, Gravina A, Riccardi F, Diana A, Mocerino C, Leopaldi L, Fabozzi A, Giordano G, Nettuno R, Incoronato P, Barzelloni ML, Caputo R, Pisano A, Grimaldi G, Genua G, Montesarchio V, Barbato E, Iodice G, Lieto E, Procaccini E, Mabilia R, Febbraro A, Laurentiis M, Ciardiello F.

ESMO Open. 2017 Jun 2;2(2):e000176. doi: 10.1136/esmoopen-2017-000176. eCollection 2017.

35.

Hemophilia Care in the Pediatric Age.

Bertamino M, Riccardi F, Banov L, Svahn J, Molinari AC.

J Clin Med. 2017 May 19;6(5). pii: E54. doi: 10.3390/jcm6050054. Review.

36.

F7 gene variants modulate protein levels in a large cohort of patients with factor VII deficiency. Results from a genotype-phenotype study.

Quintavalle G, Riccardi F, Rivolta GF, Martorana D, Di Perna C, Percesepe A, Tagliaferri A; Ad-Hoc Study Group.

Thromb Haemost. 2017 Aug 1;117(8):1455-1464. doi: 10.1160/TH17-02-0085. Epub 2017 Apr 27.

PMID:
28447100
37.

Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting.

Generali D, Montemurro F, Bordonaro R, Mafodda A, Romito S, Michelotti A, Piovano P, Ionta MT, Bighin C, Sartori D, Frassoldati A, Cazzaniga ME, Riccardi F, Testore F, Vici P, Barone CA, Schirone A, Piacentini F, Nolè F, Molino A, Latini L, Simoncini EL, Roila F, Cognetti F, Nuzzo F, Foglietta J, Minisini AM, Goffredo F, Portera G, Ascione G, Mariani G.

Oncologist. 2017 Jun;22(6):648-654. doi: 10.1634/theoncologist.2016-0461. Epub 2017 Apr 21.

38.

Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial.

Tiseo M, Boni L, Ambrosio F, Camerini A, Baldini E, Cinieri S, Brighenti M, Zanelli F, Defraia E, Chiari R, Dazzi C, Tibaldi C, Turolla GM, D'Alessandro V, Zilembo N, Trolese AR, Grossi F, Riccardi F, Ardizzoni A.

J Clin Oncol. 2017 Apr 20;35(12):1281-1287. doi: 10.1200/JCO.2016.69.4844. Epub 2017 Jan 30.

PMID:
28135143
39.

Blood Group O Protects against Inhibitor Development in Severe Hemophilia A Patients.

Franchini M, Coppola A, Mengoli C, Rivolta GF, Riccardi F, Minno GD, Tagliaferri A; ad hoc Study Group.

Semin Thromb Hemost. 2017 Feb;43(1):69-74. doi: 10.1055/s-0036-1592166. Epub 2016 Nov 8.

PMID:
27825181
40.

Long-term use of pegfilgrastim in children with severe congenital neutropenia: clinical and pharmacokinetic data.

Fioredda F, Lanza T, Gallicola F, Riccardi F, Lanciotti M, Mastrodicasa E, Signa S, Zanardi S, Calvillo M, Dufour C.

Blood. 2016 Oct 27;128(17):2178-2181. Epub 2016 Sep 12. No abstract available.

PMID:
27621310
41.

Psychological well-being and social support in chronic myeloid leukemia patients receiving lifelong targeted therapies.

Efficace F, Breccia M, Cottone F, Okumura I, Doro M, Riccardi F, Rosti G, Baccarani M.

Support Care Cancer. 2016 Dec;24(12):4887-4894. Epub 2016 Jul 23.

PMID:
27448405
42.

Neurological assessment with validated tools in general ICU: multicenter, randomized, before and after, pragmatic study to evaluate the effectiveness of an e-learning platform for continuous medical education.

Mistraletti G, Umbrello M, Anania S, Andrighi E, DI Carlo A, Martinetti F, Barello S, Sabbatini G, Formenti P, Maraffi T, Marrazzo F, Palo A, Bellani G, Russo R, Francesconi S, Valdambrini F, Cigada M, Riccardi F, Moja EA, Iapichino G; SedaICU Investigators.

Minerva Anestesiol. 2017 Feb;83(2):145-154. doi: 10.23736/S0375-9393.16.11103-4. Epub 2016 Sep 20.

43.

[Sweet heart. Hypertrophic cardiomyopathy in a 49-year-old man].

Benyamine A, Riccardi F, Coze S, Jacquier A, Chaussenot A, Paquis V, Sallée M, Aissi K, Thuny F, Frances Y, Granel B, Bauvois A, Malezieux-Picard A, Mourguet M, Murarasu A, Saada N.

Rev Med Interne. 2016 Nov;37(11):779-781. doi: 10.1016/j.revmed.2016.06.007. Epub 2016 Sep 9. French. No abstract available.

PMID:
27623328
44.

Clinical and molecular findings in 39 patients with KBG syndrome caused by deletion or mutation of ANKRD11.

Goldenberg A, Riccardi F, Tessier A, Pfundt R, Busa T, Cacciagli P, Capri Y, Coutton C, Delahaye-Duriez A, Frebourg T, Gatinois V, Guerrot AM, Genevieve D, Lecoquierre F, Jacquette A, Khau Van Kien P, Leheup B, Marlin S, Verloes A, Michaud V, Nadeau G, Mignot C, Parent P, Rossi M, Toutain A, Schaefer E, Thauvin-Robinet C, Van Maldergem L, Thevenon J, Satre V, Perrin L, Vincent-Delorme C, Sorlin A, Missirian C, Villard L, Mancini J, Saugier-Veber P, Philip N.

Am J Med Genet A. 2016 Nov;170(11):2847-2859. doi: 10.1002/ajmg.a.37878. Epub 2016 Sep 8.

PMID:
27605097
45.

Somatic, hematologic phenotype, long-term outcome, and effect of hematopoietic stem cell transplantation. An analysis of 97 Fanconi anemia patients from the Italian national database on behalf of the Marrow Failure Study Group of the AIEOP (Italian Association of Pediatric Hematology-Oncology).

Svahn J, Bagnasco F, Cappelli E, Onofrillo D, Caruso S, Corsolini F, De Rocco D, Savoia A, Longoni D, Pillon M, Marra N, Ramenghi U, Farruggia P, Locasciulli A, Addari C, Cerri C, Mastrodicasa E, Casazza G, Verzegnassi F, Riccardi F, Haupt R, Barone A, Cesaro S, Cugno C, Dufour C.

Am J Hematol. 2016 Jul;91(7):666-71. doi: 10.1002/ajh.24373. Epub 2016 Apr 24.

46.

Absence of Tumor-Infiltrating Lymphocyte Is a Reproducible Predictive Factor for Sentinel Lymph Node Metastasis: A Multicenter Database Study by the Brazilian Melanoma Group.

Duprat JP, Brechtbülh ER, Costa de Sá B, Enokihara M, Fregnani JH, Landman G, Maia M, Riccardi F, Belfort FA, Wainstein A, Moredo LF, Steck H, Brandão M, Moreno M, Miranda E, Santos ID.

PLoS One. 2016 Feb 9;11(2):e0148160. doi: 10.1371/journal.pone.0148160. eCollection 2016.

47.

Somatostatin analogues according to Ki67 index in neuroendocrine tumours: an observational retrospective-prospective analysis from real life.

Faggiano A, Carratù AC, Guadagno E, Tafuto S, Tatangelo F, Riccardi F, Mocerino C, Palmieri G, Damiano V, Siciliano R, Leo S, Mauro A, Tozzi LF, Battista C, De Rosa G, Colao A.

Oncotarget. 2016 Feb 2;7(5):5538-47. doi: 10.18632/oncotarget.6686.

48.

Cryptic 13q34 and 4q35.2 Deletions in an Italian Family.

Riccardi F, Rivolta GF, Uliana V, Grati FR, La Starza R, Marcato L, Di Perna C, Quintavalle G, Garavelli L, Rosato S, Sammarelli G, Neri TM, Tagliaferri A, Martorana D.

Cytogenet Genome Res. 2015;147(1):24-30. doi: 10.1159/000442068. Epub 2015 Dec 9.

PMID:
26645620
49.

Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study.

Arpino G, Michelotti A, Truini M, Montemurro F, Russo S, Palumbo R, Zamagni C, Latorre A, Bruzzese D, Riccardi F, De Laurentiis M, Beano A, Biganzoli L, Zaniboni A, Laudadio L, Malagoli M, Bilancia D, Schettini F, Giuliano M, Cazzaniga ME, De Placido S.

J Cancer Res Clin Oncol. 2016 Mar;142(3):669-78. doi: 10.1007/s00432-015-2033-z. Epub 2015 Aug 25.

PMID:
26531187
50.

Horner's syndrome: An unusual presentation of metastatic disease in breast cancer.

Vitale MG, Riccardi F, Carrillo G, Trunfio M, Mocerino C, Minelli S, Barbato C, Ambrosio F, Cartenì G.

Int J Immunopathol Pharmacol. 2015 Dec;28(4):557-61. doi: 10.1177/0394632015602411. Epub 2015 Sep 24.

PMID:
26405267

Supplemental Content

Loading ...
Support Center